Category Archives: Pr Newswire

Premier Health Reports 2026 First Quarter Results

MONTRÉAL, Feb. 25, 2026 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSX-V: PHA) (the “Company”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended December 31, 2025. Highlights (in thousands of Canadian dollars)   Dec. 31, 2025(3 months) Dec. 31, 2024(3 months) […]

LENSAR® Provides Update on Pending Acquisition by Alcon

ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the status of its pending acquisition by Alcon Research, LLC (“Alcon”). The Company and Alcon continue to cooperate […]

LifeStance Health Group Announces Launch of Secondary Public Offering

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company […]

SK hynix and Sandisk Begin Global Standardization of Next-Generation Memory ‘HBF’

–    SK hynix and Sandisk form a joint workstream under OCP to start standardization –    New memory layer between HBM and SSD to secure scalability and power efficiency in AI inference infrastructure SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) and Sandisk Corporation held ‘HBF Spec. Standardization Consortium Kick-Off’ […]

Vusion and Qualcomm Unveil their AI-Native Store™ Vision

A new era for associates, shoppers, and store operations powered by Bluetooth Low Energy, EdgeSense and on-device AI. PARIS, Feb. 26, 2026 /PRNewswire/ — Vusion and Qualcomm Technologies, Inc. today announced the release of “The AI-Native Store™: The New Operating System for Physical Commerce”, a jointly developed white paper describing how BLE-native infrastructure, intelligent shelves, spatial […]

Robbins Sports Surfaces Installs All-Star™ Plus Portable Court at Toyota Arena Tokyo

Toyota Arena Tokyo marks the third of Japan’s B League teams to play on a Robbins All-Star™ Plus court TOKYO, Feb. 26, 2026 /PRNewswire/ — Robbins Sports Surfaces has expanded its global presence with the installation of its All-Star™ Plus Portable Basketball Court at Toyota Arena Tokyo, the new home of Alvark Tokyo of Japan’s B League. Alvark […]

Trip.com Group Limited Reports Unaudited Fourth Quarter and Full Year of 2025 Financial Results

SINGAPORE, Feb. 26, 2026 /PRNewswire/ — Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) (“Trip.com Group” or the “Company”), a leading global one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced its unaudited financial results for the fourth quarter and full year of 2025. Key Highlights for the […]

Synergis Adept Named to G2’s 2026 Best Software Awards as Top-Ranked Engineering Document Management Platform in CAD & PLM

QUAKERTOWN, Pa., Feb. 26, 2026 /PRNewswire/ — Synergis Software announced that Synergis Adept, its engineering document management platform, has been named to G2’s 2026 Best Software Awards, ranking No. 37 in the Best CAD & PLM Software Products. Among the products recognized, Adept is the highest-ranked solution whose primary G2 category is Engineering Document Management. […]

Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria

Enrollment completed six months ahead of guidance, driven by significant unmet need for better treatments in CSU Topline data expected Q4 2026 BLA submission planned for 2027 HAMPTON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) — Celldex (NASDAQ:CLDX) announced today the completion of enrollment in the Company’s global Phase 3 program of barzolvolimab in chronic spontaneous […]

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively Reported total operating expenses of $255 million for full year 2025, within the previous guidance range Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 […]